The Therapeutics Effects of Yoga in Individuals With Parkinson's Disease

This study has been completed.
Sponsor:
Information provided by:
University of Kansas
ClinicalTrials.gov Identifier:
NCT00312559
First received: April 6, 2006
Last updated: August 17, 2007
Last verified: August 2007
  Purpose

To determine if yoga is beneficial in improving physical function quality of life and medical status in people with Parkinson's disease


Condition Intervention
Parkinson's Disease
Behavioral: Yoga Training

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind
Official Title: The Therapeutic Effects of Yoga in Individuals With Parkinson's Disease

Resource links provided by NLM:


Further study details as provided by University of Kansas:

Primary Outcome Measures:
  • Pulmonary function test, serum protein levels BP, HR, RR, strength testing using microFET, flexibility and range of motion testing using goniometer, balance/posture gait optitrk system, Berg balance scale

Secondary Outcome Measures:
  • Unified Parkinson's Disease Rating Scale
  • Hoehn & Yahr Classification Scale

Estimated Enrollment: 18
Study Start Date: February 2006
Study Completion Date: March 2007
Detailed Description:

This pilot study is a randomized controlled study of 20-30 individuals with Parkinson's disease will have a control group with no training and a research group with yoga training. The control group will have the opportunity to attend yoga training of the same intensity after the study is completed. The effects of yoga will not be on the control group. Data on physical function will be derived from assessments including strength, balance, flexibility, ROM. gait, posture and functional analysis performed in the Georgia Holland Cardiopulmonary and Neuromuscular Research Lab. Questionnaires related to quality of life, depression and falls will determine psychological impact or yoga training. Vital signs, pulmonary function tests and blood draws will be done in the General Clinical research Center (GCRC) and protein analysis will be done in the diabetes research lab.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Parkinson's Disease
  • Stage 1-3 Hoehn & Yahr

Exclusion Criteria:

  • Decline in immune function
  • 6 month joint surgery
  • spinal fusions
  • decline in mental status measured by Folstein Mini Mental Status Exam
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00312559

Locations
United States, Kansas
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160
Sponsors and Collaborators
University of Kansas
Investigators
Principal Investigator: Yvonne Searls, PT, PhD University of Kansas
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00312559     History of Changes
Other Study ID Numbers: 10214
Study First Received: April 6, 2006
Last Updated: August 17, 2007
Health Authority: United States: Institutional Review Board

Keywords provided by University of Kansas:
Parkinson's Disease

Additional relevant MeSH terms:
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases

ClinicalTrials.gov processed this record on October 19, 2014